The Association of the British Pharmaceutical Industry
Medicines are transforming our lives like never before.
We want the UK to be the best place in the world to research, develop and use the medicines and vaccines of the future.
Latest news and blogs
News |
Coalition calls for roadmap to improve inclusivity in clinical research
Blog |
Trust, transparency and purpose – managing reputation in a challenging environment
News |
Spending Review – NHS must invest more in proven innovations, says ABPI
News |
UK doubles statutory payment rate on pharmaceutical sales from July
Best practice guidance: Supporting patient organisations to report industry funding
Transparency is essential when pharmaceutical companies work with patient organisations. This updated guidance is aimed at supporting that transparency.
Guidance for conferences and events in the UK: ABPI Code of Practice requirements
This clarifies the ABPI Code requirements for conferences and events, helps all relevant stakeholders operate in a Code-compliant, professional and ethical manner.
2024 ABPI Code of Practice – new resources
The PMCPA has published new webinars and e-learning to aid understanding of the 2024 ABPI Code of Practice.
Lives Lived Well
From patients and their loved ones to those working within the pharmaceutical industry in the UK, we share a common goal: Lives Lived Well.
Events
Online Workshop on SMC: How to prepare and submit to SMC | 08-09 September 2025
Making high quality, evidence-based submissions to SMC can mean the difference between successful or very limited access to NHS Scotland for medicines.
Save the date - ABPI Industry Summit 2025
ABPI Annual Conference 2026
ABPI’s flagship annual conference will be taking place in Central London on 23 April 2026.
ABPI response to the new Industrial Strategy
The government’s new Industrial Strategy reaffirms its commitment to growing the economy. The key test for life sciences will be whether it can return the UK to international competitiveness.
Key facts and figures for the pharmaceutical industry in the UK
£46.7bn
Turnover [6]
£9bn
investment in UK R&D (more than UKRI’s entire annual budget) [3]
£17.6bn
direct Gross Value Added (GVA) [1]